CSPAM
LLY icon

Cary Street Partners Asset Management’s Eli Lilly LLY Stock Holding History

Cary Street Partners Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-200
Closed -$68.7K – 309
2023
Q1 		$68.7K Hold
200
– – 0.01% 219
2022
Q4 		$73.2K Buy
200
+182
+1,011% +$64.5K 0.01% 236
2022
Q3 		$6K Buy
+18
New +$5.7K ﹤0.01% 359

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Cary Street Partners Asset Management's LLY Position: Q2 2023 in Review

Cary Street Partners Asset Management sold out of Eli Lilly (LLY) in Q2 2023, closing a stake of 200 shares — an estimated $68.7K sold.

Cary Street Partners Asset Management first reported a position in LLY in Q3 2022 and held it in 3 quarters. The position peaked at $73.2K in Q4 2022. 2,814 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

  • Cary Street Partners Asset Management reported no remaining Eli Lilly position as of Q2 2023 after selling out during the quarter.
  • Cary Street Partners Asset Management sold 200 Eli Lilly shares in Q2 2023, an estimated $68.7K.
  • Cary Street Partners Asset Management first reported a position in Eli Lilly in Q3 2022 and held it in 3 quarters.
  • Cary Street Partners Asset Management's Eli Lilly position peaked at $73.2K in Q4 2022.
  • 2,814 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on Cary Street Partners Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.